Intellectual Property News & Topics - Secerna LLP

WAKIX (1)

A to Z: Drugs in Highlight: W is for WAKIX®

News A to Z Feature 08/05/2025

Our A to Z series highlights WAKIX® (from Bioprojet Pharma) which is used to treat narcolepsy in adults, adolescents and children from 6 years of age. The active substance in WAKIX® is pitolisant. Pitolisant works by blocking histamine from attaching to the histamine H3 receptor on nerve cells.

Read more

Building A Robust Biotech Patent Portfolio

Industry news, News 30/05/2024

Building a Robust Patent Portfolio to Navigate the Biotech Landscape

World Intellectual Property Organization Geneva

Industry news, News 24/05/2024

Landmark U.N. Treaty on Intellectual Property, Genetic Resources, and Associated Traditional Knowledge

Laos

European, News 22/05/2024

New Route to Patent Protection in Laos through validation of European Patents

EPO

European, Industry news, News 15/05/2024

Claim interpretation using the description: Potential referral to the EPO Enlarged Board of Appeal

Copy Of 9CF4E240 F92E 4BA4 A8BE 6358DCBCA18B 1 105 C

Events, News 03/05/2024

Seas the Day takes on the Pacific in 8,000-Mile row with Secerna's support

Secerna Website Images 2023 (44)

News 28/04/2024

Unlocking Your Design's Potential: Protect Your Creation with Design Rights

Secerna Website Images 2023 (43)

News 26/04/2024

World Intellectual Property Day: Unleashing Sustainable Innovation Through IP

IP Protection For Metaverse And Other Immersive Technologies

News 18/04/2024

Secure Your Metaverse Advantage: A Guide to IP Protection

Ireland UPC

European, Industry news, News, UPC 15/04/2024

Irish Participation in the Unified Patent Court: Update on Referendum

7 8 9 10 11 12 13 14 15 16 17